Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Block for Postoperative Analgesia After Laparoscopic Nephrectomy
NCT04085237Terminated
- Sponsor
- McMaster University
- Start
- Jan 2020
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in Persistent postsurgical pain (PPSP) (2 arms), sponsored by McMaster University. Primary endpoint: Enrollment rate of greater than one patient per week with 100% in-hospital follow-up at 1 week. Started Jan 2020; status: terminated.
02
Drugs
ropivacaine
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT04085237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04085237.